Company Website

Contacts

Joan Padrnos-Heinz
jpadrnos-heinz@blueprintmedicines.com
612-991-1821

Virtual Exhibit Hall Home

Blueprint Medicines is a global precision therapy company that aims to invent transformative medicines for people with cancer and hematologic disorders. We are delivering our approved therapies to patients in the United States and Europe, and we are globally advancing multiple programs for genomically defined cancers, systemic mastocytosis, and cancer immunotherapy.

Additional Information

Gavreto (pralsetinib) RET altered mNSCLC & Thyroid Cancer  

Ayvakit (avapritinib) Advanced Systemic Mastocytosis  

YourBlueprint Patient Services Overview